Hydralazine Hydrochloride
Overview
Hydralazine Hydrochloride is a potent vasodilator used in the treatment of hypertension and heart failure. It works by relaxing blood vessels, improving blood flow, and decreasing cardiac workload.
API suppliers (8)
Suppliers of Hydralazine Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 7 of 8 suppliers.
5 of 8 hold a GMP certificate on record in the EU or UK registers
- ARCHIMICA SPAItaly1 active DMF GMP on record
- AMI LIFESCIENCES PRIVATE LTDIndia1 active DMF GMP on record
- SUMITOMO CHEMICAL CO LTDJapan1 active DMF GMP on record
- Hetero Labs LimitedIndia1 active DMF GMP on record
- Macleods Pharmaceuticals Ltd.India1 active DMF GMP on record
- WANBURY LTDIndia1 active DMF
- DAIWA PHARMACEUTICAL CO LTD
- Siegfried LTDUnited Kingdom
EU CEP holders (6)
Companies holding a valid EU Certificate of Suitability (CEP) for Hydralazine Hydrochloride, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Therapeutic areas
Do you supply Hydralazine Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.